| Date Filed | Type | Description |
| 05/15/2023 |
4
| Freiman Paul E. (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Exercised 858 restricted stock units
@ $0 |
|
| 05/15/2023 |
4
| Zheng Yenyou (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Exercised 858 restricted stock units
@ $0 |
|
| 05/15/2023 |
4
| WU MIJIA (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Exercised 858 restricted stock units
@ $0 |
|
| 05/15/2023 |
4
| Sit Swan (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Exercised 858 restricted stock units
@ $0 |
|
| 05/15/2023 |
4
| Garlikov Julie (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Exercised 858 restricted stock units
@ $0 |
|
| 05/15/2023 |
4
| Zheng Yongxiang (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Exercised 858 restricted stock units
@ $0 |
|
| 02/24/2023 |
3
| Law Tommy (Interim CFO) has filed a Form 3 on NovaBay Pharmaceuticals, Inc. |
| 12/07/2022 |
4
| Kunin Audrey (Chief Product Officer) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Sold 1 shares
@ $1.81, valued at
$1.8 |
|
| 12/07/2022 |
4
| Kunin Jeffrey (President, DERMAdoctor, LLC) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Sold 1 shares
@ $1.81, valued at
$1.8 |
|
| 12/05/2022 |
4/A
| Kunin Audrey (Chief Product Officer) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Sold 5,960 shares
@ $2.1049, valued at
$12.5k
|
|
| 12/05/2022 |
4/A
| Kunin Jeffrey (President, DERMAdoctor, LLC) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Sold 5,960 shares
@ $2.1049, valued at
$12.5k
|
|
| 11/23/2022 |
4
| Kunin Audrey (Chief Product Officer) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Sold 5,960 shares
@ $2.1049, valued at
$12.5k
|
|
| 11/23/2022 |
4
| Kunin Jeffrey (President, DERMAdoctor, LLC) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Sold 5,960 shares
@ $2.1049, valued at
$12.5k
|
|
| 09/16/2022 |
4
| Hall Justin (CEO, GC and Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Bought 10,000 shares
@ $0.15, valued at
$1.5k
|
|
| 09/16/2022 |
4
| Kunin Jeffrey (President, DERMAdoctor, LLC) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Sold 291,368 shares
@ $0.1582, valued at
$46.1k
|
|
| 09/16/2022 |
4
| Kunin Audrey (Chief Product Officer) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Sold 291,368 shares
@ $0.1582, valued at
$46.1k
|
|
| 05/24/2022 |
4
| WU MIJIA (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Exercised 30,000 restricted stock units
@ $0 |
|
| 05/24/2022 |
4
| Zheng Yenyou (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Exercised 30,000 restricted stock units
@ $0 |
|
| 05/24/2022 |
4
| Freiman Paul E. (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Exercised 30,000 restricted stock units
@ $0 |
|
| 05/24/2022 |
4
| Sit Swan (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Exercised 30,000 restricted stock units
@ $0 |
|
| 05/13/2022 |
4
| WU MIJIA (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 restricted stock units
@ $0 |
|
| 05/13/2022 |
4
| Sit Swan (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 restricted stock units
@ $0 |
|
| 05/13/2022 |
4
| Zheng Yongxiang (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 restricted stock units
@ $0 |
|
| 05/13/2022 |
4
| Zheng Yenyou (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 restricted stock units
@ $0 |
|
| 05/13/2022 |
4
| Garlikov Julie (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 restricted stock units
@ $0 |
|
| 05/13/2022 |
4
| Freiman Paul E. (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 restricted stock units
@ $0 |
|
| 02/10/2022 |
3
| Zheng Yongxiang (Director) has filed a Form 3 on NovaBay Pharmaceuticals, Inc. |
| 02/03/2022 |
3
| Garlikov Julie (Director) has filed a Form 3 on NovaBay Pharmaceuticals, Inc. |
| 12/07/2021 |
4
| Kunin Jeffrey (President, DERMAdoctor, LLC) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Bought 101,650 shares
@ $0.4625, valued at
$47k
|
|
| 12/07/2021 |
4
| Kunin Audrey (Chief Product Officer) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Bought 101,650 shares
@ $0.4625, valued at
$47k
|
|
| 12/06/2021 |
4
| Hall Justin (CEO, GC and Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Bought 69,767 shares
@ $0.43, valued at
$30k
|
|
| 12/06/2021 |
4
| Kunin Jeffrey (President, DERMAdoctor, LLC) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Bought 262,369 shares
@ $0.476, valued at
$124.9k
|
|
| 12/06/2021 |
4
| Kunin Audrey (Chief Product Officer) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Bought 262,369 shares
@ $0.476, valued at
$124.9k
|
|
| 12/06/2021 |
4
| Jones Andrew D. (CFO) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Bought 8,690 shares
@ $0.44, valued at
$3.8k
Bought 36,765 shares
@ $0.44, valued at
$16.2k
|
|
|